Mohammed I. Khan, M.D.
Interventional Pain Medicine Physician · Coppell, TX
Mohammed I. Khan, M.D. is an interventional pain medicine physician with a practice address in Coppell, Texas, and NPI 1891982278, issued on Sep 28, 2007. Check the license (Texas N0883, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.
- Name
- Mohammed I. Khan
- Credential
- M.D.
- Primary taxonomy
- Interventional Pain Medicine Physician 208VP0014X
- License numbers
- N0883 TX
MT196139 TX
Self-reported in NPPES; status is on the state search - Practice location
- 149 E State Highway 121, Coppell, TX 75019
- Phone
- (806) 441-8841
- Enumerated
- Sep 28, 2007
- Record last updated
- Nov 28, 2022
- Medicare enrollment
- Enrolled (PECOS I20141223002243); accepts Medicare assignment
- Medical or professional school
- Texas Tech University Health Science Center School Of Medicine, 2007
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
8 nearest interventional pain medicine physician records → All 301 in Texas → Look up another NPI →
Verify Mohammed I. Khan in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersTexas Medical Board
Search for license N0883Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
76% fewer Medicare Part D claims than the average interventional pain medicine physician in 2024
543 Medicare Part D claims for 90 beneficiaries, against an average of 2,306 among the 2,100 providers of this specialty who prescribed in Part D. Brand-name drugs were 6% of claims. 385 claims were for opioids.
Most prescribed
- Hydrocodone-Acetaminophen281 claims
- Gabapentin27 claims
- Acetaminophen-Codeine20 claims
- Oxycodone Hcl20 claims
- Tizanidine Hcl20 claims
- Morphine Sulfate18 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $648.03
5 payments; by number, the most common kind was travel and lodging; the largest payer was Abbott Laboratories. The 1,966 providers of this specialty with any payment received $3,889.53 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Siai PLLCCoppell, TX
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Mohammed I. Khan among 301 interventional pain medicine physician records in Texas
Mohammed I. Khan, M.D. is one of 301 interventional pain medicine physician records with a practice address in Texas. 91% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2007, is newer than 41% of them.
- NPI issued2007 · 41% of these records are older, 45% newer
- In a Medicare fileYes · 91% of these records are
- In the CMS Doctors and Clinicians fileYes · 83% of these records are
- Graduated2007 · median 2004 among the 250 with a school on file
- Record last updated2022 · 36% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 208VP0014X and a Texas practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Interventional Pain Medicine Physician providers in Texas
There are 301 interventional pain medicine physician records in Texas.
All 301 in Texas → Every provider in Coppell → Interventional Pain Medicine Physician nationwide →
The 8 interventional pain medicine physician records with the nearest ZIP codes
- Shiv Sharma, MDCoppell, TX 750191518929397
- Muhammad Arif, MDPlano, TX 750241952561631
- Oliver Ghalambor, M.D.Allen, TX 750131710008966
- Jeremy Epstein, MDCarrollton, TX 750101831533058
- Paul Kurian, D.O.Carrollton, TX 750101942261672
- Timur Yasin, M.D.Flower Mound, TX 750281194960658
- Ahmed Abdel Rahman, MD, FRCPC, MBARockwall, TX 750321316972698
- Waqas Ali, DORockwall, TX 750321942861638
Common questions
What is Mohammed I. Khan, M.D.'s NPI number?
Mohammed I. Khan, M.D.'s National Provider Identifier (NPI) is 1891982278, issued on Sep 28, 2007. An NPI identifies a provider in billing; it is not a license.
Where is Mohammed I. Khan, M.D. located?
The NPPES record lists a practice address at 149 E State Highway 121, Coppell, TX, 75019. Phone: (806) 441-8841. Providers update this record themselves, so call before visiting.
How can I verify Mohammed I. Khan, M.D.'s license?
NPPES lists Texas license number N0883, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Mohammed I. Khan, M.D. prescribe under Medicare Part D?
In 2024, Mohammed I. Khan, M.D. had 543 Medicare Part D claims for 90 beneficiaries; the average among interventional pain medicine physician prescribers was 2,306. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.